HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Akira Yoshida Selected Research

Cytokines

7/2021Detection of cytokine storm in patients with achalasia using ELISA.
1/2021Impact of endoscopic submucosal dissection and epithelial cell sheet engraftment on systemic cytokine dynamics in patients with oesophageal cancer.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Akira Yoshida Research Topics

Disease

28Neoplasms (Cancer)
05/2022 - 01/2003
14Leukemia
10/2014 - 05/2002
12Type 2 Diabetes Mellitus (MODY)
12/2021 - 09/2013
10Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
10/2014 - 01/2003
8Esophageal Achalasia (Megaesophagus)
07/2021 - 11/2011
8Neoplasm Metastasis (Metastasis)
07/2016 - 02/2009
7Carcinoma (Carcinomatosis)
08/2013 - 11/2003
5Adenoma (Adenomas)
01/2022 - 01/2008
5Insulin Resistance
12/2021 - 01/2015
5Body Weight (Weight, Body)
12/2021 - 01/2018
5Thyroid Neoplasms (Thyroid Cancer)
09/2021 - 09/2006
5Anaplastic Thyroid Carcinoma
01/2020 - 05/2005
5Infarction (Infarctions)
01/2017 - 03/2007
5Overactive Urinary Bladder (Overactive Bladder)
01/2016 - 08/2009
4Stomach Neoplasms (Stomach Cancer)
01/2022 - 01/2014
4Disease Progression
09/2014 - 07/2012
4Breast Neoplasms (Breast Cancer)
08/2013 - 02/2009
3Pain (Aches)
05/2021 - 05/2017
3Pathologic Constriction (Stenosis)
01/2021 - 04/2012
3Diabetic Retinopathy (Retinopathy, Diabetic)
02/2017 - 09/2013
3Infections
04/2016 - 03/2010
3Tumor Lysis Syndrome
05/2015 - 10/2014
3Hematologic Neoplasms (Hematological Malignancy)
05/2015 - 10/2014
3Thrombosis (Thrombus)
01/2013 - 01/2010
3Cerebral Infarction
01/2013 - 03/2007
3Papillary Carcinoma
11/2012 - 11/2003
3Myelodysplastic Syndromes (Myelodysplastic Syndrome)
09/2012 - 01/2003
3Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia)
03/2010 - 05/2002
2Exanthema (Rash)
02/2022 - 03/2010
2Paralysis (Palsy)
01/2022 - 03/2007
2Chronic Renal Insufficiency
11/2020 - 04/2019
2Multiple Myeloma
12/2017 - 10/2013
2Peritonitis
11/2017 - 08/2013
2Bone Resorption
09/2017 - 05/2017
2Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse)
02/2015 - 11/2012
2Atopic Dermatitis (Atopic Eczema)
12/2014 - 04/2003
2Hypoxia (Hypoxemia)
10/2013 - 10/2006
2Hematologic Diseases (Blood Diseases)
04/2013 - 10/2012
2Refractory Anemia
09/2012 - 01/2003
2Disseminated Intravascular Coagulation
01/2011 - 01/2010

Drug/Important Bio-Agent (IBA)

12Glucose (Dextrose)FDA LinkGeneric
12/2021 - 03/2007
7SurvivinIBA
12/2017 - 01/2003
6DNA (Deoxyribonucleic Acid)IBA
10/2013 - 10/2003
6Messenger RNA (mRNA)IBA
08/2013 - 01/2003
5SodiumIBA
11/2020 - 01/2018
5Proteins (Proteins, Gene)FDA Link
01/2018 - 01/2003
4Sodium-Glucose Transporter 2 InhibitorsIBA
12/2021 - 01/2018
4dapagliflozinIBA
08/2018 - 06/2018
4Uric Acid (Urate)IBA
05/2015 - 09/2013
4Muscarinic Receptors (Muscarinic Acetylcholine Receptor)IBA
01/2014 - 08/2009
4Cytarabine (Cytosar-U)FDA LinkGeneric
07/2013 - 02/2007
4RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA
05/2005 - 01/2003
3AcidsIBA
05/2022 - 05/2020
3AntibodiesIBA
05/2022 - 11/2003
3Glycated Hemoglobin (Glycosylated Hemoglobin)IBA
01/2022 - 06/2015
3MicroRNAs (MicroRNA)IBA
01/2021 - 08/2017
3Insulin (Novolin)FDA Link
05/2020 - 01/2015
3SymportersIBA
08/2018 - 01/2018
3GlucocorticoidsIBA
07/2018 - 05/2002
3Muscarinic AntagonistsIBA
01/2016 - 01/2010
3Inhibitor of Apoptosis ProteinsIBA
05/2013 - 01/2003
3Pharmaceutical PreparationsIBA
10/2012 - 09/2002
3Glutathione (Reduced Glutathione)IBA
03/2010 - 05/2002
3Caspase 3 (Caspase-3)IBA
01/2006 - 05/2002
2lenvatinibIBA
09/2021 - 01/2020
2CytokinesIBA
07/2021 - 01/2021
2Biomarkers (Surrogate Marker)IBA
01/2021 - 08/2017
2AlbuminsIBA
01/2021 - 06/2018
2Biological ProductsIBA
05/2020 - 06/2012
2Indicators and Reagents (Reagents)IBA
12/2019 - 10/2016
2Hemoglobins (Hemoglobin)IBA
04/2019 - 08/2018
2Cyclophosphamide (Cytoxan)FDA LinkGeneric
07/2018 - 02/2015
2AntigensIBA
01/2018 - 10/2011
2sepantroniumIBA
12/2017 - 05/2013
2Calcitonin (Calcitonin, Eel)FDA LinkGeneric
09/2017 - 05/2017
2elcatoninIBA
09/2017 - 05/2017
2IodineIBA
07/2016 - 11/2012
2LDL CholesterolIBA
01/2016 - 04/2010
2Paclitaxel (Taxol)FDA LinkGeneric
01/2016 - 06/2015
2Solifenacin SuccinateFDA Link
01/2016 - 08/2009
2Rituximab (Mabthera)FDA Link
02/2015 - 08/2005
2Prednisolone (Predate)FDA LinkGeneric
02/2015 - 05/2003
2Vincristine (Oncovin)FDA LinkGeneric
02/2015 - 05/2003
2Doxorubicin (Adriamycin)FDA LinkGeneric
02/2015 - 05/2003
2Xanthine OxidaseIBA
12/2014 - 10/2014
2FebuxostatFDA Link
12/2014 - 10/2014
2Small Interfering RNA (siRNA)IBA
10/2013 - 05/2005
2Nucleic AcidsIBA
09/2013 - 09/2012
2Rose BengalIBA
01/2013 - 01/2013
2Glial Cell Line-Derived Neurotrophic Factor (GDNF)IBA
01/2013 - 03/2007
2Capecitabine (Xeloda)FDA Link
11/2012 - 02/2009

Therapy/Procedure

24Therapeutics
06/2022 - 07/2002
10Drug Therapy (Chemotherapy)
01/2022 - 05/2003
7Myotomy
01/2021 - 11/2011
4Activities of Daily Living (ADL)
01/2022 - 07/2002
3Glycemic Control
06/2018 - 02/2017
3Thyroidectomy
08/2014 - 01/2011
2Lasers (Laser)
05/2020 - 12/2011
2Conservative Treatment
01/2019 - 03/2010
2Radiotherapy
09/2014 - 05/2009